Skip to content

GREENVEIL

Spike glycoprotein (human sars coronavirus) peptide (P8-540-559)

Concern score

Not assessed — no hazard data yet.

Spike glycoprotein (human sars coronavirus) peptide (P8-540-559) in plain language

What it is

Also known as Cga 227731 · CGA227731 · CGA227731 (P8) · P8

What it does

We don't have a plain-language description for Spike glycoprotein (human sars coronavirus) peptide (P8-540-559) yet.

Is it a concern?
We haven't assessed a concern score for this ingredient yet.

What we know about this ingredient

EPA DSSTox provides the canonical identifier, structure, and synonym profile for this chemical.

Regulation

No restrictions found. Spike glycoprotein (human sars coronavirus) peptide (P8-540-559) appears in these published regulatory listings.

  • USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as protein.
    • openFDA substance registry classifies this ingredient as protein.Source →

Evidence & sources

No graded research studies for Spike glycoprotein (human sars coronavirus) peptide (P8-540-559) yet. This record is compiled from the published data sources below — registries and regulatory listings, not study findings.

3 data sources

Where this comes from

  • EPA DSSTox Identifiers

    chemistry · updated 2025-12-29

    Open →

  • FDA GSRS UNII

    registry · updated 2026-02-26

    Open →

  • openFDA Substance

    registry · updated 2026-05-24

    Open →
Reference links (1)

Suitability

Context-specific fit derived from published classifications and the current ingredient evidence profile.

Fragrance avoidance

Nothing to weigh for this context yet.

No signal in this context

We have no published hazard signal for this ingredient, so we cannot say how it behaves in this context — that is missing evidence, not a clean result.